The development of cancer is not a process triggered immediately by the emergence of an oncogenic mutation. There is growing evidence for the existence of an intermediate phase—hitherto poorly defined ...

Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in ...

Researchers say their achievement represents an important step toward the development of a new immunotherapy for solid tumors ...

Senior Punjab Minister Marriyum Aurangzeb on Sunday announced that a state-of-the-art cancer hospital would be established in ...

Cancer genomes are unstable, often experiencing gains or losses of whole chromosomes or chromosome arms — changes known as aneuploidies. Experiments in mouse models of breast cancer reveal that these ...

A computer illustration of an inflamed digestive system. (Science Photo Library/Canva) Inflammatory bowel disease affects ...

Researchers developed Oncoformer, a multimodal transformer that analyzes longitudinal health records and chest X-rays to ...

NYU Langone Health and Dana-Farber Cancer Institute have formed a strategic collaboration to co-develop Solavia Decision ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a ...

Introduction Compassion is a core value in person-centred nursing and is essential in the care of patients with cancer. However, existing measurement instruments often fail to capture the cultural, ...

Cancer drugs known as BET inhibitors once looked like a breakthrough, but in real patients they’ve often fallen short. New research reveals a key reason why: two closely related proteins, BRD2 and ...